<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36013984</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus Infection and Associated Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1566</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms10081566</ELocationID><Abstract><AbstractText>Coxsackieviruses (CV) are ubiquitous and widespread single-stranded RNA viruses belonging to the <i>Picornaviridae</i> family and the genus <i>Enterovirus</i>, which also includes poliovirus (PV), the best known of the enteroviruses (EV) [...].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nekoua</LastName><ForeName>Magloire Pandoua</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0002-2981-0803</Identifier><AffiliationInfo><Affiliation>Laboratoire de Virologie ULR3610, Université Lille et CHU Lille, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hober</LastName><ForeName>Didier</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4301-2074</Identifier><AffiliationInfo><Affiliation>Laboratoire de Virologie ULR3610, Université Lille et CHU Lille, 59000 Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36013984</ArticleId><ArticleId IdType="pmc">PMC9414633</ArticleId><ArticleId IdType="doi">10.3390/microorganisms10081566</ArticleId><ArticleId IdType="pii">microorganisms10081566</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bodian D. Emerging concept of poliomyelitis infection. Science. 1955;122:105–108. doi: 10.1126/science.122.3159.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.122.3159.105</ArticleId><ArticleId IdType="pubmed">14385825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bopegamage S., Berakova K., Gomocak P., Baksova R., Galama J., Hyoty H., Tauriainen S. Primary site of coxsackievirus B replication in the small intestines: No proof of peyer’s patches involvement. Microorganisms. 2021;9:2600. doi: 10.3390/microorganisms9122600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9122600</ArticleId><ArticleId IdType="pmc">PMC8709031</ArticleId><ArticleId IdType="pubmed">34946201</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua M.P., Alidjinou E.K., Hober D. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2022;18:503–516. doi: 10.1038/s41574-022-00688-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone V.M., Ringqvist E.E., Larsson P.G., Domsgen E., Holmlund U., Sverremark-Ekström E., Flodström-Tullberg M. Inhibition of type III interferon expression in intestinal epithelial cells—A strategy used by coxsackie B virus to evade the host’s innate immune response at the primary site of infection? Microorganisms. 2021;9:105. doi: 10.3390/microorganisms9010105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9010105</ArticleId><ArticleId IdType="pmc">PMC7824802</ArticleId><ArticleId IdType="pubmed">33466313</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazmi A., Nekoua M.P., Michaux H., Sane F., Halouani A., Engelmann I., Alidjinou E.K., Martens H., Jaidane H., Geenen V., et al. Effect of coxsackievirus B4 infection on the thymus: Elucidating its role in the pathogenesis of type 1 diabetes. Microorganisms. 2021;9:1177. doi: 10.3390/microorganisms9061177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061177</ArticleId><ArticleId IdType="pmc">PMC8229779</ArticleId><ArticleId IdType="pubmed">34072590</ArticleId></ArticleIdList></Reference><Reference><Citation>Halouani A., Michaux H., Jmii H., Trussart C., Chahbi A., Martens H., Renard C., Aouni M., Hober D., Geenen V., et al. Coxsackievirus B4 transplacental infection severely disturbs central tolerogenic mechanisms in the fetal thymus. Microorganisms. 2021;9:1537. doi: 10.3390/microorganisms9071537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9071537</ArticleId><ArticleId IdType="pmc">PMC8303261</ArticleId><ArticleId IdType="pubmed">34361972</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter D.L., Thuma J.R., Malgor R., Schwartz F.L., McCall K.D., Coschigano K.T. Consequences of both coxsackievirus B4 and type 1 diabetes on female non-obese diabetic mouse kidneys. Microorganisms. 2021;9:2357. doi: 10.3390/microorganisms9112357.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9112357</ArticleId><ArticleId IdType="pmc">PMC8623636</ArticleId><ArticleId IdType="pubmed">34835482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasrado N., Arumugam R., Rasquinha M.T., Sur M., Steffen D., Reddy J. Mt10-CVB3 vaccine virus protects against CVB4 infection by inducing cross-reactive, antigen-specific immune responses. Microorganisms. 2021;9:2323. doi: 10.3390/microorganisms9112323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9112323</ArticleId><ArticleId IdType="pmc">PMC8622534</ArticleId><ArticleId IdType="pubmed">34835449</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>